Skip to content

Therapeutic effect of vitamin D on Hashimoto thyroiditis

Therapeutic effect of vitamin D on Hashimoto thyroiditis

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20180228038900N1
Enrollment
30
Registered
2018-04-16
Start date
2018-04-21
Completion date
Unknown
Last updated
2018-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hashimoto thyroiditis. Disorders of other endocrine glands

Interventions

Intervention group: Low levels of vitamin D treatment: First, check blood levels of vitamin D at levels below 30 ng / ml: 1. Low levels of vitamin D between 20 and 30 ng / ml. Pearl contains 50000 uni

Sponsors

Babol University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
2 Years to 18 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: All patients under the age of 18 with diagnosis of Hashimoto thyroiditis based on laboratory findings and ultrasonography.

Exclusion criteria

Exclusion criteria: Exit criteria: Patients with thyroid disease, with or without goiter, with normal levels of antibodies, are excluded.Patients with Hashimoto thyroiditis who were already treated.Patients with thyroid disease with or without goiter have normal levels of autoantibodies.Patients with certain chromosomal syndromes, including Down or Turner.Patients with liver and kidney disease.

Design outcomes

Primary

MeasureTime frame
Primary outcome : The therapeutic effects of vitamin D on the level of thyroid autoantibodies in Hashimoto thyroiditis. Timepoint: Time zero and six months later. Method of measurement: blood test.

Secondary

MeasureTime frame
Secondary outcomes: The therapeutic effects of vitamin D on reducing thyroid gland in Hashimoto thyroiditis. Timepoint: Time zero and six months later. Method of measurement: sonography.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMorteza Aljanpour Aghamaleki

Babol University of Medical Sciences

m.alijanpour@mubabol.ac.ir+98 11 3234 6963

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026